Correlation Between Spyre Therapeutics and Abcellera Biologics
Can any of the company-specific risk be diversified away by investing in both Spyre Therapeutics and Abcellera Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spyre Therapeutics and Abcellera Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spyre Therapeutics and Abcellera Biologics, you can compare the effects of market volatilities on Spyre Therapeutics and Abcellera Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of Abcellera Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and Abcellera Biologics.
Diversification Opportunities for Spyre Therapeutics and Abcellera Biologics
0.6 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Spyre and Abcellera is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and Abcellera Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abcellera Biologics and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with Abcellera Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abcellera Biologics has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and Abcellera Biologics go up and down completely randomly.
Pair Corralation between Spyre Therapeutics and Abcellera Biologics
Given the investment horizon of 90 days Spyre Therapeutics is expected to under-perform the Abcellera Biologics. But the stock apears to be less risky and, when comparing its historical volatility, Spyre Therapeutics is 1.12 times less risky than Abcellera Biologics. The stock trades about -0.02 of its potential returns per unit of risk. The Abcellera Biologics is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 260.00 in Abcellera Biologics on August 29, 2024 and sell it today you would earn a total of 40.00 from holding Abcellera Biologics or generate 15.38% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Spyre Therapeutics vs. Abcellera Biologics
Performance |
| Timeline |
| Spyre Therapeutics |
| Abcellera Biologics |
Spyre Therapeutics and Abcellera Biologics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Spyre Therapeutics and Abcellera Biologics
The main advantage of trading using opposite Spyre Therapeutics and Abcellera Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, Abcellera Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abcellera Biologics will offset losses from the drop in Abcellera Biologics' long position.| Spyre Therapeutics vs. Bright Minds Biosciences | Spyre Therapeutics vs. HP Inc | Spyre Therapeutics vs. Intel | Spyre Therapeutics vs. Chevron Corp |
| Abcellera Biologics vs. Bright Minds Biosciences | Abcellera Biologics vs. HP Inc | Abcellera Biologics vs. Intel | Abcellera Biologics vs. Chevron Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Stocks Directory Find actively traded stocks across global markets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |